Related Experiment Video
Updated: Feb 28, 2026

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
Published on: February 2, 2024
Rhizopus homothallicus Causing Invasive Infections: Series of Three Cases from a Single Centre in North India
Prathyusha Kokkayil1, Mragnayani Pandey2, Reshu Agarwal2
1Department of Microbiology, Government Medical College, Palakkad, Kerala, 678013, India.
Abstract:
Mucormycoses are opportunistic fungal infections with a high mortality rate. Rhizopus oryzae is the most common agent implicated in human infections. Although R. homothallicus has been previously reported to be a cause of pulmonary mucormycosis, it is the first time that we are reporting as a causative agent of rhino-orbital and cutaneous mucormycosis.
Insights
This study identifies Rhizopus homothallicus as a new cause of severe rhino-orbital and cutaneous mucormycosis. This finding expands our understanding of fungal infections and their agents.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Microbiology
Background:
- Mucormycoses are severe opportunistic fungal infections with high mortality rates.
- Rhizopus oryzae is the most frequently identified causative agent of human mucormycoses.
- Previous reports have linked Rhizopus homothallicus to pulmonary mucormycosis.
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Acute Pyelonephritis I: Introduction
